Related Experiment Video
Updated: Jul 15, 2026

Monitoring Neuronal Survival via Longitudinal Fluorescence Microscopy
Published on: January 19, 2019
TRAIL signalling: decisions between life and death
Christina Falschlehner1, Christoph H Emmerich, Björn Gerlach
1Division of Apoptosis Regulation (D040), Tumor Immunology Program, German Cancer Research Center (DKFZ), Im Neuenheimer Feld 580, 69120 Heidelberg, Germany.
Abstract:
The TNF-related apoptosis-inducing ligand, TRAIL, has been shown to selectively kill tumour cells. This property has made TRAIL and agonistic antibodies against its death inducing receptors (TRAIL-R1 and TRAIL-R2) to some of the most promising novel biotherapeutic agents for cancer therapy. Here we review the signalling pathways initiated by the apoptosis- as well as the non-apoptosis-inducing receptors, TRAIL-R3 and TRAIL-R4. The TRAIL "death-inducing signalling complex" (DISC) transmits the apoptotic signal. DISC formation leads to activation of a protease cascade, finally resulting in cell death. The TRAIL death receptor-mediated "extrinsic" pathway and the "intrinsic" pathway, which is controlled by the interaction of members of the Bcl-2 family, interact with each other in the decision about life or death of a cell. Apoptotic and non-apoptotic signalling is influenced by the NF-kappaB, PKB/Akt and the MAPK signalling pathways. In this review we intend to summarise the most important findings on the TRAIL signalling network and the interplay in the decisions between life and death of a tumor cell.
Insights
Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) selectively kills cancer cells, making it a promising biotherapeutic. This review details TRAIL
Area of Science:
- Molecular Biology
- Cell Biology
- Cancer Research
Background:
- Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) selectively induces apoptosis in tumor cells.
- TRAIL and agonistic antibodies targeting TRAIL-R1/TRAIL-R2 are promising cancer therapeutics.
- TRAIL receptors include apoptosis-inducing (TRAIL-R1, TRAIL-R2) and non-apoptosis-inducing (TRAIL-R3, TRAIL-R4) types.
Purpose of the Study:
- To review the signaling pathways initiated by TRAIL receptors.
- To elucidate the interplay between apoptosis and non-apoptosis signaling in TRAIL pathways.
- To summarize key findings on the TRAIL signaling network and its role in tumor cell fate.
Main Methods:
- Review of existing literature on TRAIL signaling pathways.
- Analysis of the formation and function of the TRAIL death-inducing signaling complex (DISC).
- Examination of the interaction between extrinsic (TRAIL-mediated) and intrinsic apoptosis pathways.
Main Results:
- DISC formation triggers a protease cascade leading to apoptosis.
- TRAIL signaling involves crosstalk between extrinsic and intrinsic apoptosis pathways.
- NF-kappaB, PKB/Akt, and MAPK pathways modulate both apoptotic and non-apoptotic TRAIL signaling.
Conclusions:
- TRAIL-mediated apoptosis is a complex process involving multiple signaling pathways.
- Understanding TRAIL signaling networks is crucial for developing effective cancer therapies.
- The balance between apoptotic and non-apoptotic signaling determines tumor cell survival or death.
Related Concept Videos
Diversity in Cell Signaling Responses
Graded and Abrupt Responses
Some signaling systems generate...
Ethical Dilemmas II
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Kubler Ross's Stages of Dying
In denial, individuals reject the reality of their condition, often thinking, "This isn't true; I feel fine," as a way to protect themselves from emotional distress. Anger...
Life Histories
Overview of Cell Death
Cell death was observed in the early 19th century, but there was no experimental evidence to prove it. In 1842, Carl Vogt first discovered cell death in a metamorphic toad; however, it was not termed ‘cell death.’ Scientists discovered different cell death pathways only in the 20th century...

